Steven M Hallford, CRNA | |
1407 Whisenant Dr, Duncan, OK 73533 | |
(580) 251-8847 | |
(580) 251-8869 |
Full Name | Steven M Hallford |
---|---|
Gender | Male |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 28 Years |
Location | 1407 Whisenant Dr, Duncan, Oklahoma |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1932160165 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | R0076172 (Oklahoma) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Duncan Regional Hospital, Inc | Duncan, OK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Duncan Anesthesia Associates Inc | 7719984590 | 7 |
News Archive
Integra LifeSciences Holdings Corporation announced today that Linda Littlejohns RN MSN CCRN CNRN, Vice President, Clinical Development at Integra, has been selected as a Fellow of the American Academy of Nursing, one of the most prestigious nursing organizations in the country. The Academy's Fellows include many of the nation's top nursing executives, policymakers, scholars, researchers and practitioners.
A panel of 19 microRNAs identified using next-generation sequencing could categorize indeterminate thyroid nodule samples into malignant and benign.
Although finding effective screening tools remains a priority, new treatment options for women with ovarian cancer, such as the ones outlined in the updated NCCN Guidelines for Ovarian Cancer, are vital to making steady progress against the disease according to Robert J. Morgan, MD, of City of Hope Comprehensive Cancer Center and chair of the NCCN Guidelines Panel for Ovarian Cancer.
Type 1 diabetes (T1D) is an autoimmune disease that develops when the immune system attacks beta cells in the pancreas. This destructive process is often attributed to autoreactive T lymphocytes. Yet the innate immune system, our body's first line of defense, also plays an important role in this disease.
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that in one study, the majority of rheumatoid arthritis patients on an ultra-low dose of the drug rituximab maintained low disease activity for up to four years, and rarely needed to switch to other biologic drugs or glucocorticoids to control their disease.
› Verified 4 days ago
Entity Name | Duncan Anesthesia Associates Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205897410 PECOS PAC ID: 7719984590 Enrollment ID: O20061109000222 |
News Archive
Integra LifeSciences Holdings Corporation announced today that Linda Littlejohns RN MSN CCRN CNRN, Vice President, Clinical Development at Integra, has been selected as a Fellow of the American Academy of Nursing, one of the most prestigious nursing organizations in the country. The Academy's Fellows include many of the nation's top nursing executives, policymakers, scholars, researchers and practitioners.
A panel of 19 microRNAs identified using next-generation sequencing could categorize indeterminate thyroid nodule samples into malignant and benign.
Although finding effective screening tools remains a priority, new treatment options for women with ovarian cancer, such as the ones outlined in the updated NCCN Guidelines for Ovarian Cancer, are vital to making steady progress against the disease according to Robert J. Morgan, MD, of City of Hope Comprehensive Cancer Center and chair of the NCCN Guidelines Panel for Ovarian Cancer.
Type 1 diabetes (T1D) is an autoimmune disease that develops when the immune system attacks beta cells in the pancreas. This destructive process is often attributed to autoreactive T lymphocytes. Yet the innate immune system, our body's first line of defense, also plays an important role in this disease.
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that in one study, the majority of rheumatoid arthritis patients on an ultra-low dose of the drug rituximab maintained low disease activity for up to four years, and rarely needed to switch to other biologic drugs or glucocorticoids to control their disease.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Steven M Hallford, CRNA 1111 W Willow Ave, Ste 106, Duncan, OK 73533 Ph: (580) 252-6366 | Steven M Hallford, CRNA 1407 Whisenant Dr, Duncan, OK 73533 Ph: (580) 251-8847 |
News Archive
Integra LifeSciences Holdings Corporation announced today that Linda Littlejohns RN MSN CCRN CNRN, Vice President, Clinical Development at Integra, has been selected as a Fellow of the American Academy of Nursing, one of the most prestigious nursing organizations in the country. The Academy's Fellows include many of the nation's top nursing executives, policymakers, scholars, researchers and practitioners.
A panel of 19 microRNAs identified using next-generation sequencing could categorize indeterminate thyroid nodule samples into malignant and benign.
Although finding effective screening tools remains a priority, new treatment options for women with ovarian cancer, such as the ones outlined in the updated NCCN Guidelines for Ovarian Cancer, are vital to making steady progress against the disease according to Robert J. Morgan, MD, of City of Hope Comprehensive Cancer Center and chair of the NCCN Guidelines Panel for Ovarian Cancer.
Type 1 diabetes (T1D) is an autoimmune disease that develops when the immune system attacks beta cells in the pancreas. This destructive process is often attributed to autoreactive T lymphocytes. Yet the innate immune system, our body's first line of defense, also plays an important role in this disease.
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that in one study, the majority of rheumatoid arthritis patients on an ultra-low dose of the drug rituximab maintained low disease activity for up to four years, and rarely needed to switch to other biologic drugs or glucocorticoids to control their disease.
› Verified 4 days ago
Matthew W Roberson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1407 Whisenant Dr, Duncan, OK 73533 Phone: 580-251-8847 Fax: 580-251-8869 | |
Janice K Palovik, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1407 Whisenant Dr, Duncan, OK 73533 Phone: 580-251-8847 Fax: 580-251-8869 | |
Homer L Cox, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1407 Whisenant Dr, Duncan, OK 73533 Phone: 580-251-8847 Fax: 580-251-8869 | |
Mr. Jeffrey L Hopkins, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1308 Highiand Way, Duncan, OK 73533 Phone: 580-467-7185 | |
Andrew P Flesher, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1407 Whisenant Dr, Duncan, OK 73533 Phone: 580-251-8847 Fax: 580-251-8869 |